(Press-News.org) DETROIT - Co-existing psychiatric illness should be considered in assessing hospital readmissions for three common medical conditions used by Medicare and Medicaid to penalize hospitals with "excessive" readmission rates.
That was the conclusion of a newly published collaborative study by 11 major U.S. healthcare providers - including Henry Ford Health System - affiliated with the nationwide Mental Health Research Network (MHRN).
The study is published in Psychiatric Services.
The subject of readmission rates has been of increasing concern to U.S. hospitals since October 2012, when the Centers for Medicare and Medicaid Services (CMS) tied readmissions to reimbursement as part of the Affordable Care Act, informally known as Obamacare.
"CMS chose three general medical conditions - heart failure, acute myocardial infarction and pneumonia - as a way of assessing excessive re-hospitalizations and penalizing providers by reducing payment for healthcare services," says Henry Ford researcher Brian K. Ahmedani, Ph.D., lead author of the new study. Dr. Ahmedani is a researcher at the Center for Health Policy and Health Services Research.
"The policy was adopted as a way to curb rising healthcare costs and improve quality of care, and CMS chose those three conditions because they're common, expensive to treat, and often result in readmission."
Hospital readmissions account for a large share of healthcare spending in the U.S., including more than $17 billion of Medicare costs each year. In attempting to reduce excessive readmissions - those occurring within 30 days of a patient's original hospitalization - CMS is expected to add other medical conditions to the three already used as standards.
"So to avoid reimbursement penalties, it is very important for healthcare providers across the U.S. to develop effective interventions to reduce 30-day readmissions," Ahmedani explains. "The question is, where to start to provide the most reductions in readmissions at the lowest cost?
"Our current study chose to focus on psychiatric conditions."
Psychiatric illness was already known to be highly comorbid - existing at the same time as another medical condition - with heart failure, acute myocardial infarction (AMI) and pneumonia.
Two smaller previous studies were conducted at a single healthcare site and produced conflicting results: one showed higher rates of 30-day readmissions, and the other found lower rates.
The new study identified more than 160,000 patients who had been admitted to the 11 MHRN-affiliated healthcare centers between January 2009 and December 2011 for any of the three medical conditions targeted by CMS. It was the largest and most geographically diverse investigation of its kind.
Analysis of the data found that patients with psychiatric comorbidities in the previous year were readmitted to the hospital 3 to 5 percent more often within 30 days than those without a psychiatric diagnosis.
Perhaps even more troubling, the researchers noted, is that nearly 30 percent of those admitted to the hospital with heart failure, AMI or pneumonia were diagnosed in the previous year as having a mental health condition.
Most important, the study concluded, individuals with a psychiatric concern probably accounted for an even larger proportion of admissions for heart failure, AMI or pneumonia, but because mental health conditions are often not diagnosed, these illnesses weren't captured in medical records.
"These findings suggest that psychiatric comorbidities influence 30-day all-cause readmission rates for individuals with heart failure, AMI and pneumonia," Ahmedani says.
"Because depression, anxiety and substance abuse appeared to be the most common diagnoses among the patients we studied, and because each was associated with increased readmission rates, these disorders may be the most appropriate for healthcare systems to focus their primary screening efforts."
Using this knowledge to target patients at higher risk of readmission, the study concluded, it may be possible to make progress toward the long-term goal of improving the quality and cost of healthcare and easing the risk to hospitals of CMS penalties for excessive readmissions.
INFORMATION:
The study was conducted by researchers in the Mental Health Research Network (MHRN), a consortium of 13 large healthcare systems with affiliated health insurance plans. The MHRN systems serve over 12.5 million individuals across 15 states with diverse populations. Sites participating in this study and their primary locations included Group Health Cooperative (Washington), Harvard Pilgrim Health Care (Massachusetts), HealthPartners (Minnesota), Henry Ford Health System (Michigan), Kaiser Permanente (Colorado), Kaiser Permanente (Georgia), Kaiser Permanente (Hawaii), Kaiser Permanente Northern (California), Kaiser Permanente Northwest (Oregon), Kaiser Permanente Southern (California), and Baylor Scott & White Health (Texas). Institutional review boards at each site approved data use for this project.
Scientists at Columbia University's Mailman School of Public Health report that children with autism spectrum disorder (ASD) were two-and-a-half times more likely to have persistent gastrointestinal (GI) symptoms as infants and toddlers than children with typical development. Results are published in JAMA Psychiatry.
The study is based on a large longitudinal survey of Norwegian mothers who were asked about their child's GI disturbances during the first three years of life. Questionnaires were completed when the children were 18 and 36 months of age.
The authors ...
Gastrointestinal symptoms reported by mothers were more common and more often persistent in the first three years of life in children with autism spectrum disorder than in children with typical development and developmental delay, according to an article published online by JAMA Psychiatry.
Autism spectrum disorders (ASDs) are characterized by problems in social communication and interaction, as well as restricted/repetitive behaviors. Medical and psychiatric conditions are frequently associated with ASD and among the most common are gastrointestinal (GI) symptoms and ...
A new analysis of surgical outcomes nationwide concludes that more use of minimally invasive surgery for certain common procedures can dramatically reduce post-operative complications and shave hundreds of millions of dollars off the nation's health care bill.
Results of the research, conducted by Johns Hopkins investigators and published March 25 in JAMA-Surgery, indicate that American hospitals collectively could prevent thousands of post-surgical complications and save between $280 million and $340 million a year by using more minimally invasive procedures instead ...
A small imaging study suggests prenatal exposure to polycyclic aromatic hydrocarbons (PAHs), the toxic air pollution caused in part by vehicle emissions, coal burning and smoking, may be bad for children's brains and may contribute to slower processing speeds and behavioral problems, including attention-deficit-hyperactivity-disorder (ADHD) symptoms, according to an article published online by JAMA Psychiatry.
PAHs are caused by the incomplete combustion of organic materials. In addition to outdoor air pollution, sources of indoor air pollution caused by PAHs can be cooking, ...
A variety of dialectical behavior therapy (DBT) interventions helped to reduce suicide attempts and nonsuicidal self-injury acts in a randomized clinical trial of women with borderline personality disorder who were highly suicidal, according to an article published online by JAMA Psychiatry.
DBT is a multicomponent therapy for individuals at high risk for suicide and for those with multiple severe mental disorders, particularly those who have marked impulsivity and an inability to regulate emotions. The components of DBT include individual therapy, group skills training, ...
Magnetic nanoparticles can open the blood-brain barrier and deliver molecules directly to the brain, say researchers from the University of Montreal, Polytechnique Montréal, and CHU Sainte-Justine. This barrier runs inside almost all vessels in the brain and protects it from elements circulating in the blood that may be toxic to the brain. The research is important as currently 98% of therapeutic molecules are also unable to cross the blood-brain barrier. "The barrier is temporary opened at a desired location for approximately 2 hours by a small elevation of the temperature ...
BETHESDA, MD, USA and VIENNA, AUSTRIA - Two of the world's largest professional societies of human geneticists have issued a joint position statement on the promise and challenges of non-invasive prenatal testing (NIPT), a new procedure to test blood drawn from pregnant mothers for Down syndrome and other chromosomal disorders in the fetus. The document addresses the current scope of and likely future improvements in NIPT technology, ways it may best fit with existing prenatal screening tools and protocols, options and priorities in its implementation, and associated social ...
This news release is available in French. Montreal, March 25, 2015 -- "Create a password" is a prompt familiar to anyone who's tried to buy a book from Amazon or register for a Google account. Equally familiar is that red / yellow / green bar that rates the new password's strength. But when those meters give the go-ahead to passwords like Password1+, their effectiveness is called into question.
New research from Concordia University exposes the weakness of password strength meters, and shows consumers should remain sceptical when the bar turns green in order to create ...
From AGU's blogs: Q&A with journalist-turned-geologist Rex Buchanan
After decades as a science reporter, interim director of the Kansas Geological Survey (KGS) Rex Buchanan now finds himself at the epicenter of a media frenzy. Read parts one and two of a three-part series featuring an interview between Buchanan and University of California, Santa Cruz, science journalism student, Kerry Klein, in The Plainspoken Scientist.
From Eos.org: Changing of the Guard: Satellite Will Warn Earth of Solar Storms
This summer, Earth gets a new guardian--the Deep Space Climate ...
ATLANTA--Medication used to treat patients with type II diabetes activates sensors on brain cells that increase hunger, causing people taking this drug to gain more body fat, according to researchers at Georgia State University, Oregon Health and Science University, Georgia Regents University and Charlie Norwood Veterans Administration Medical Center.
The study, published on March 18 in The Journal of Neuroscience, describes a new way to affect hunger in the brain and helps to explain why people taking a class of drugs for type II diabetes gain more body fat.
Type II ...